About the Company

[Summary] RNA药物研发商

上海伊诺瑞康生物医药科技有限公司成立于2022年,是由中科院生化与细胞研究所的资深教授带领青年团队创立的高新科技企业,专注于RNA药物的开发与产业化,致力于成为*的RNA药物研发企业。
伊诺瑞康设立之初就获得知名投资机构数千万的天使轮投资,公司研发中心位于张江药谷和浦江智慧广场,建立了包括RNA序列AI设计、核苷酸修饰、高通量筛选、RNA大量制备工艺等RNA创新药物开发的关键技术,并积极拓展在细胞治疗和基因治疗领域的创新应用。伊诺瑞康研发团队多年深耕于RNA研究领域,在国际著名期刊发表多篇高质量文章,具备出色的技术创新能力,务实、开放、团结的工作氛围。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

伊诺瑞康 Financing History (2 rounds)

Manage
A轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 融资金额未公开
  • Investor: 瑞夏投资,富汇创投

伊诺瑞康 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

伊诺瑞康 Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 235万(元)
Legal Representative: 张英
Date Established:
Credit Code: 91310117MA7J60G527
Registered Address: 中国(上海)自由贸易试验区张江路665号三层

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates